Using a radioalloster to test predictions of the cooperativity model for gallamine binding to the allosteric site of muscarinic acetylcholine M2 receptors

Molecular Pharmacology

Volumn 56, Issue 5, 1999, Pages 962-965

  Tränkle, Christian ^a   Weyand, Oliver ^a   Schröter, Alexandra ^a   Mohr, Klaus ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GALLAMINE; METHYLSCOPOLAMINE; MUSCARINIC M2 RECEPTOR;

ALLOSTERISM; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR OCCUPANCY;

EID: 0041775707     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.56.5.962     Document Type: Article

References (23)

1. Birdsall NJM, Farries T, Gharagozloo P, Kobayashi S, Kuonen D, Lazareno S, Popham A and Sugimoto M (1997) Selective allosteric enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypes. Life Sci 60:1047-1052.
2. Birdsall NJM, Farries T, Gharagozloo P, Kobayashi S, Lazareno S and Sugimoto M (1999). Subtype-selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: Functional studies. Mol Pharmacol 55:778-786.
3. 1 receptor binding and function by 2-amino-3-benzoylthiophenes. Mol Pharmacol 38:939-949.
4. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
5. Christopoulos A, Lanzafame A and Mitchelson F (1998) Allosteric interactions at muscarinic cholinoceptors. Clin Exp Pharmacol and Physiol 25:185-194.
6. 3H]acetylcholine release from rat striatum by muscarinic receptor agonists. Br J Pharmacol 124:1213-1218.
7. DeBlasi A, O'Reilly K and Motulsky HJ (1989) Calculating receptor number from binding experiments using same compound as radioligand and competitor. Trends Pharmacol Sci 10:227-229.
8. Ehlert FJ (1988) Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol Pharmacol 35:187-194.
9. Ellis J (1997) Allosteric binding sites on muscarinic receptors. Drug Dev Res 40:193-204.
10. Ellis J and Seidenberg M (1992) Two allosteric modulators interact at a common site on cardiac muscarinic receptors. Mol Pharmacol 42:638-641.
11. 2 dopamine receptors by amiloride and amiloride analogs. Mol Pharmacol 50:1295-1308.
12. Holzgrabe U and Mohr K (1998) Allosteric modulators of ligand binding to muscarinic acetylcholine receptors. Drug Discovery Today 3:214-222.
13. Hulme EC (1992) Centrifugation binding assays, in Receptor Ligand Interactions - A Practical Approach (Hulme EC ed) p 235, Oxford University Press, New York.
14. Lazareno S and Birdsall NJM (1995) Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: Interactions of strychnine and acetylcholine at muscarinic receptors. Mol Pharmacol 48:362-378.
15. Lee NH and El-Fakahany EE (1991) Allosteric antagonists of the muacarinc acetylcholine receptor. Biochem Pharmacol 42:199-205.
16. Leppik RA, Lazareno S, Mynett A and Birdsall NJM (1998) Characterization of the allosteric interactions between antagonists and amiloride analogues at the human alpha2A-adrenergic receptor. Mol Pharmacol 53:916-925.
17. + exchange. J Biol Chem 262:12387-12392.
18. Stockton JM, Birdsall NJM, Burgen ASV and Hulme EC (1983) Modification of the binding properties of muscarinic receptors by gallamine. Mol Pharmacol 23:551-557.
19. Tränkle C, Kostenis E, Burgmer U and Mohr K (1996) Search for lead structures to develop new allosteric modulators of muscarinic receptors. J Pharmacol Exp Ther 279:926-933.
20. 3H]ligand for the common allosteric site of muscarinic acetylcholine receptors. Mol Pharmacol 54:139-145.
21. 2 receptors. Mol Pharmacol 51:674-682.
22. Tuček S and Proška J (1995) Allosteric modulation of muscarinic acetylcholine receptors. Trends Pharmacol Sci 16:205-212.
23. + exchange. Mol Pharmacol 42:75-179.